Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 25, 2018

BUY
$5.06 - $6.78 $201,241 - $269,647
39,771 New
39,771 $324,000
Q1 2018

May 01, 2018

SELL
$5.43 - $8.36 $215,956 - $332,485
-39,771 Closed
0 $0
Q4 2017

Feb 05, 2018

SELL
$8.15 - $10.55 $24,450 - $31,650
-3,000 Reduced 7.01%
39,771 $324,000
Q3 2017

Nov 03, 2017

BUY
$10.45 - $11.44 $446,956 - $489,300
42,771
42,771 $448,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $50.2M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.